| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/10/2006 | US20060177490 Chitosan-base antimicrobial thermoplastic polymer blends |
| 08/10/2006 | US20060177489 Attachment of chitosan to surfaces using rehydration process |
| 08/10/2006 | US20060177488 Abrasive wipe for treating a surface |
| 08/10/2006 | US20060177487 Moisture and lotion retainer |
| 08/10/2006 | US20060177481 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 08/10/2006 | US20060177478 Intravascular blood conditioning device and use thereof |
| 08/10/2006 | US20060177430 Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer |
| 08/10/2006 | US20060177417 Packaged form containing complex of polypeptide and macromolecular carrier |
| 08/10/2006 | US20060177414 Pharmaceutical preparations for oral adminstration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents |
| 08/10/2006 | US20060177402 Synthetic tear fluid |
| 08/10/2006 | US20060177383 Stable tooth whitening gum with reactive ingredients |
| 08/10/2006 | US20060177382 Delivery of antiemetics through an inhalation route |
| 08/10/2006 | US20060177374 Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments |
| 08/10/2006 | DE60115222T2 Kombination von defibrotid und g-csf und ihre verwendung zur aktivierung hämatopoietischer vorläuferzellen Progenitor cell combination of defibrotide and g-csf and their use for the activation of hematopoietic |
| 08/10/2006 | DE60024843T2 Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten Containing vaccines for oral use the liposome and a nucleic acid |
| 08/10/2006 | DE19708803B4 Verfahren zur Kontrolle des Gewichts von gekörnten Produkten an Vielfach-Dosiermaschinen und eine ein solches Verfahren ausführende Dosiermaschine A method for controlling the weight of granular products to multiple dosing and such a process executing metering |
| 08/10/2006 | DE102005005449A1 Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform A process for preparing a secured against abuse dosage form |
| 08/10/2006 | DE102005005446A1 Bruchfeste Darreichungsformen mit retardierter Freisetzung Unbreakable dosage forms with delayed release |
| 08/10/2006 | CA2829533A1 Contact drug delivery system |
| 08/10/2006 | CA2644400A1 Fast wet-massing method for the preparation of calcium-containing compositions |
| 08/10/2006 | CA2601773A1 Compositions of unconjugated estrogens and methods for their use |
| 08/10/2006 | CA2601762A1 Dosage forms providing controlled and immediate release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors |
| 08/10/2006 | CA2601755A1 Melt granulation of a composition containing a calcium-containing compound |
| 08/10/2006 | CA2596966A1 Implantable osmotic device for continuous delivery of suspension formulations |
| 08/10/2006 | CA2596933A1 Devices for delivering agents to a vaginal tract |
| 08/10/2006 | CA2596860A1 Method for reducing the level of peroxides in bopcompatible polymer preparations |
| 08/10/2006 | CA2596759A1 Local treatment of neurofibromas |
| 08/10/2006 | CA2596731A1 Nucleic acid constructs |
| 08/10/2006 | CA2596730A1 Adjuvanting material comprising pam2cys or pam3cys covalently linked to a metal chelating group |
| 08/10/2006 | CA2596280A1 Compositions and methods for less immunogenic protein formulations |
| 08/10/2006 | CA2596189A1 Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints |
| 08/10/2006 | CA2596178A1 Method for producing a drug extract that contains hydroxystilbene |
| 08/10/2006 | CA2595979A1 Method for the production of a tamper-proof form of administration |
| 08/10/2006 | CA2595860A1 Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks |
| 08/10/2006 | CA2595792A1 Cd20 antibody variants and uses thereof |
| 08/10/2006 | CA2595409A1 Oral dosage form comprising rosiglitazone |
| 08/10/2006 | CA2593043A1 Drug delivery materials made by sol/gel technology |
| 08/09/2006 | EP1688481A1 Bifidobacterium in the treatment of inflammatory disease |
| 08/09/2006 | EP1688432A1 Igm high concentration stabilized solution |
| 08/09/2006 | EP1688169A1 Method for producing fine organic compound particles |
| 08/09/2006 | EP1688149A1 Paste formulations comprising silica |
| 08/09/2006 | EP1688143A2 Niacin-containing substained-release tablets and kits |
| 08/09/2006 | EP1688142A1 Terfenadine carboxylate and the treatment of dermal irritation |
| 08/09/2006 | EP1688139A1 Creatine ester pronutrient compounds and formulations |
| 08/09/2006 | EP1688134A2 Dry powder inhaler for transpulmonary administration |
| 08/09/2006 | EP1688133A1 Freeze-dried composition for transpulmonary administration |
| 08/09/2006 | EP1688132A2 Microchip devices for delivery of molecules and methods of fabrication thereof |
| 08/09/2006 | EP1688131A1 Orally disintegratable tablet forming a viscous slurry |
| 08/09/2006 | EP1688130A1 Micronized vitamin C formulation |
| 08/09/2006 | EP1688129A1 New therapeutic formulation |
| 08/09/2006 | EP1687267A2 Modified mscl protein channel |
| 08/09/2006 | EP1687043A2 Electrical devices and anti-scarring agents |
| 08/09/2006 | EP1687031A1 Pharmaceutical preparation containing an antibody for the egf receptor |
| 08/09/2006 | EP1687012A1 Stabilisation of viral microparticles |
| 08/09/2006 | EP1687011A2 Modified whole cell, cell extract and omv-based vaccines |
| 08/09/2006 | EP1686974A1 Extended release dosage forms of bupropion hydrochloride |
| 08/09/2006 | EP1686969A1 Transdermal pharmaceutical spray formulations comprising a vp/va copolymer and a non-aqueous vehicle |
| 08/09/2006 | EP1686968A2 Osmotic pump with self-retaining, fast-start membrane plug |
| 08/09/2006 | EP1686967A2 Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
| 08/09/2006 | EP1686966A1 Low-dose tablets having a network of polymers |
| 08/09/2006 | EP1686965A2 Solid pharmaceutical preparation form |
| 08/09/2006 | EP1686964A1 Microparticles comprising somatostatin analogues |
| 08/09/2006 | EP1686963A1 Suspension delivery system for the sustained and controlled local release of pharmaceuticals |
| 08/09/2006 | EP1686962A2 Nanoparticulate compositions having a peptide as a surface stabilizer |
| 08/09/2006 | EP1686961A1 Solid forms of anti-egfr-antibodies |
| 08/09/2006 | EP1686960A2 Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same |
| 08/09/2006 | EP1686959A2 Pharmaceutical formulations employing short-chain sphingolipids and their use |
| 08/09/2006 | EP1686958A1 Controlled food effect composition |
| 08/09/2006 | EP1575559B1 Dosing aerosols containing lecithin as a surface-active substance |
| 08/09/2006 | EP1458387B1 Orodispersible tablets containing fexofenadine |
| 08/09/2006 | EP1453949B1 Production of cell suspensions |
| 08/09/2006 | EP1390138B1 Vegetable protein-based microcapsules |
| 08/09/2006 | EP1383483A4 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 08/09/2006 | EP1363637B1 Pyrimidine compounds and methods for their preparation |
| 08/09/2006 | EP1354032B1 Gene regulation therapy involving ferritin |
| 08/09/2006 | EP1309640B1 Polyurethane film-forming dispersions in an alcohol-water system |
| 08/09/2006 | EP1221940B1 Liposome formulation of 6,9-bis- (2-aminoethyl)-amino|benzo g|isoquinoline-5,10-dione dimaleate |
| 08/09/2006 | EP1183275B1 Specific antibodies against human chorionic gonadotropin and their use in therapy and diagnostic |
| 08/09/2006 | EP1178782B1 Transdermal therapeutic system (tts) containing tolterodine |
| 08/09/2006 | EP1146900B1 Dna vaccines against hantavirus infections |
| 08/09/2006 | EP1144003B1 Methods and devices for delivery of agents to breast milk ducts |
| 08/09/2006 | EP1077722B1 Methods and products for inducing mucosal immunity |
| 08/09/2006 | EP1007098B1 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides |
| 08/09/2006 | EP0827513B1 Reagents for treatment and diagnostic visualisation, particularly in cancer |
| 08/09/2006 | EP0752004B1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 08/09/2006 | CN2803426Y Medicinal magnetic therapeutic patch |
| 08/09/2006 | CN2803382Y Fresh and cooling fragrance stickers |
| 08/09/2006 | CN2803381Y Bigeminal capsule |
| 08/09/2006 | CN1816626A Antisense oligonucleotide having anticancerous activity |
| 08/09/2006 | CN1816617A Method for storing tumor cells |
| 08/09/2006 | CN1816538A Preventive or therapeutic composition for viral infectious disease |
| 08/09/2006 | CN1816495A Zeolites for delivery of nitric oxide |
| 08/09/2006 | CN1816355A Tablet and process for producing the same |
| 08/09/2006 | CN1816331A Tumor-targeting drug-loaded particles |
| 08/09/2006 | CN1816325A Hydrophilic adhesives for delivery of herbal medicines |
| 08/09/2006 | CN1816324A Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| 08/09/2006 | CN1816323A Controlled release compositions of betahistine |
| 08/09/2006 | CN1816322A Particulate materials |
| 08/09/2006 | CN1814616A Buxine, buxine hydrochloride, and its preparing method and formulation |
| 08/09/2006 | CN1814612A Ammonia maleate rubicin salt, and its preparing method and use |